In turn, TNF-α induced the elevation of IL-35 secretion by PBMCs, which further promoted the release of IL-1β and IL-6 in RA patients [32], suggesting the proinflammatory potential of IL-35 in RA pathogenesis. Here, IL6 is linked to rheumatoid arthritis.